Biochemical alterations as measures of acute and subacute hepatotoxicity of 1,3-dibromobenzene in rat.
Rats were used to study acute and subacute hepatotoxicity of 1,3-dibromobenzene (1,3-dBB). In the single-exposure experiment, maximum hepatic 1,3-dBB concentrations were found to occur 1 to 12 h after the exposure, depending on the dose. Maximum concentrations of covalently bound adducts were reached after 12 h. Depletion of hepatic glutathione (GSH) content occurred during the first 24 h following the exposure, but was not accompanied by changes in alanine aminotransferase (ALT) activity. The increased number of doses also did not result in necrotic lesions of the liver. In the subacute (28-day) experiment, higher hepatic GSH levels and increased blood serum gamma-glutamyltransferase (gamma-GT) activity were observed. Exposure to 1,3-dBB resulted in increased porphyrin excretion in urine, without accompanying increase in the removal of delta-aminolevulinic acid (AlA-U). The results indicate that subacute exposure to 1,3-dBB produces porphyrinuria in the rat.
Szymańska
J A
JA
Department of Toxicological Chemistry, Medical University of Lódź, Poland.
D000818:Animals; D001969:Bromobenzenes / Q000633:toxicity*; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D005978:Glutathione / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008107:Liver Diseases / Q000378:metabolism; D008111:Liver Function Tests; D008315:Malondialdehyde / Q000378:metabolism; D011166:Porphyrins / Q000652:urine; D051381:Rats; D017208:Rats, Wistar
D001969:Bromobenzenes; D011166:Porphyrins; C102880:1,3-dibromobenzene; D008315:Malondialdehyde; D005978:Glutathione